Terawan Agus Putranto, Terawan Agus
Faculty of Medicine, Hasanuddin University, Makassar-Indonesia

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Intra Arterial Heparin Flushing Increases Manual Muscle Test – Medical Research Councils (MMT-MRC) Score in Chronic Ischemic Stroke Patient Putranto, Terawan Agus; Yusuf, Irawan; Murtala, Bachtiar; Wijaya, Andi
BALI MEDICAL JOURNAL Vol 5 No 2 (2016)
Publisher : BALI MEDICAL JOURNAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (250.936 KB)

Abstract

Background: Muscle strength impairment in stroke patient affect the patient daily life, especially when it occurs on the extremities muscles. Manual Muscle Testing (MMT) is an examination method to measure muscle strength using standardized scoring. Objective: To find possible improvement of Manual Muscle Test (MMT) Score after administration of Intra Arterial Heparin Flushing in chronic ischemic stroke patient. Method: This is an experimental study using pretest-posttest group design, with randomized controlled clinical trial, conducted among patients in Cerebrovascular Center Unit in Army Central Hospital Gatot Soebroto starting from February 2014. With 75 patients included in this study. The examination of muscle strength was done by trained physicians. The MMT score were taken before and after the IAHF procedure is conducted. Results: This study found higher score of MMTMRC scoring system on chronic stroke patient with IAHF procedure (mean MMT-MRC Score = 6,05 point. With p
Endobronchial hamartoma: Diagnostic challenges and clinical implications of a rare benign lung tumor Fazharyasti, Vininta; Wahyono, Djuwita Adi; Wardhana, Samuel Raymond Rumantir; Putranto, Terawan Agus
Jurnal Prima Medika Sains Vol. 7 No. 1 (2025): June
Publisher : Program Studi Magister Kesehatan Masyarakat Universitas Prima Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.34012/jpms.v7i1.6112

Abstract

Introduction: Endobronchial hamartomas are rare benign lung tumors, representing only 0.025%–0.032% of all lung tumors and 1.4% of hamartomas. Originating in the bronchial passages, these tumors comprise cartilage, fat, fibrous tissue, and epithelium. Despite their benign nature, they can cause bronchial obstruction, post-obstructive pneumonia, and atelectasis. Case Report: A 68-year-old male presented with chronic cough and hemoptysis. Imaging revealed a calcified mass in the right lower bronchus, causing partial obstruction. Bronchoscopy identified a smooth, obstructive mass without bleeding or necrosis. Histopathological examination confirmed an endobronchial hamartoma, showing benign bronchial mucosa, cartilage, adipose tissue, submucosal glands, and myxoid stroma. Discussion: Diagnosing endobronchial hamartomas is challenging due to their rarity, nonspecific symptoms, and nonspecific imaging findings. Advanced imaging techniques, such as computed tomography (CT) scans, can identify calcifications or fatty components, aiding diagnosis. However, histopathological confirmation is crucial to differentiate these lesions from malignant or other benign pulmonary tumors. Early recognition and treatment are essential to prevent complications like recurrent infections and irreversible airway damage. Conclusion: Although rare, endobronchial hamartoma is a clinically significant benign lung tumor due to its potential to cause notable complications. The diagnostic challenge lies in its often nonspecific initial imaging findings. However, combining advanced radiology modalities, such as computed tomography (CT) and histopathological evaluation. Early recognition of this tumor from other pulmonary lesions is crucial for treatment and better patient outcomes.